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The commonality of many neurodegenerative disorders is
the predictable temporal occurrence and progression
of specific aggregated proteins in the brain. The hallmark
proteopathy is Alzheimer’s disease in which aggregated
amyloid-b peptide (Ab) is deposited in the brain paren-
chyma as amyloid plaques. Multiple evidence suggests that
b-amyloidosis is induced by aggregated Ab which can
spread within and among brain regions and act as corrup-
tive templates (seeds) that induce a chain-reaction of Ab
misfolding and aggregation. The insight that the prion
paradigm may also apply to cerebral b-amyloidosis and
other proteopathies suggests new avenues in search of bio-
markers and novel therapeutic strategies.
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